Skip to content
Home/Companies/HealthTech/DermaPharm
DermaPharm

DermaPharm

HealthTech·Denmark·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns DermaPharm?

DermaPharm is a Danish HealthTech company, currently owned by ARCHIMED since 2025.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQDenmark
SectorHealthTech
Websitedermapharm.dk

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
Natus Sensory
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Title21 Health Solutions
Active
HealthTechUS· 2022
Aliri
Aliri
Active
PharmaUS· 2021
Cardioline
Cardioline
Active
MedTechItaly· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns DermaPharm?

DermaPharm is currently owned by ARCHIMED, through MED III, since 2025.

When did ARCHIMED acquire DermaPharm?

ARCHIMED acquired DermaPharm in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue